Clinical trial
Bexarotene With Narrow-Band UVB for Psoriasis
NCT00151008 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00151008 |
|---|---|
| Title | Bexarotene With Narrow-Band UVB for Psoriasis |
| Official title | Investigator-Initiated, Double Blind, Vehicle-Controlled, Bilateral Comparison Trial of Bexarotene (Targretin) Gel 1% vs. Vehicle Gel in Combination With Narrow Band UVB Phototherapy for Moderate to Severe Psoriasis Vulgaris |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | Ligand Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Bexarotene/NBUVB vs placebo NBUVB |
| Enrollment | 35 |
| Start date | Nov 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Aug 7, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: